Abstract
The International Agency for Research on Cancer recently convened a Working Group of Experts (June 11-18, 1991) to discuss the use of information on carcinogenesis mechanisms in carcinogenic risk identification. The role of cell proliferation in carcinogenesis was among the items discussed in detail. It was recognized that cell proliferation is an important mechanistic aspect for both genotoxic and nongenotoxic carcinogens. It may act at each stage of the carcinogenesis process, altering the size of the pool of cells at risk for a next event. Cell proliferation was considered to be important, especially as a) an integral part of the process of converting DNA adducts to mutation, b) an enhancing factor for the mutation frequency by inducing errors in replication, and c) an important factor in determining dose-response relationships for some carcinogens. It was also recognized that not all agents that induce cell proliferation are necessarily involved in carcinogenesis; for example, a) not all skin hyperplasia-inducing compounds are skin tumor promoters, b) agents that induce "regenerative" cell proliferation appear to have different effects on tumor induction from agents that have a direct mitogenic effect, and c) the carcinogenic activity of many nonmutagenic agents depends on the continuous administration of the agent. In addition, tissues with a high rate of cell proliferation do not have a higher risk of developing cancer. Thus, no simple relationship exists between cell proliferation and carcinogenesis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BOUTWELL R. K. SOME BIOLOGICAL ASPECTS OF SKIN CARCINOGENISIS. Prog Exp Tumor Res. 1964;4:207–250. doi: 10.1159/000385978. [DOI] [PubMed] [Google Scholar]
- Cohen S. M., Ellwein L. B. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res. 1991 Dec 15;51(24):6493–6505. [PubMed] [Google Scholar]
- Dominick M. A., Robertson D. G., Bleavins M. R., Sigler R. E., Bobrowski W. F., Gough A. W. Alpha 2u-globulin nephropathy without nephrocarcinogenesis in male Wistar rats administered 1-(aminomethyl)cyclohexaneacetic acid. Toxicol Appl Pharmacol. 1991 Dec;111(3):375–387. doi: 10.1016/0041-008x(91)90244-9. [DOI] [PubMed] [Google Scholar]
- Huff J. Absence of morphologic correlation between chemical toxicity and chemical carcinogenesis. Environ Health Perspect. 1993 Dec;101 (Suppl 5):45–53. doi: 10.1289/ehp.93101s545. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Loeb L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 1991 Jun 15;51(12):3075–3079. [PubMed] [Google Scholar]
- Strauss B. S. The origin of point mutations in human tumor cells. Cancer Res. 1992 Jan 15;52(2):249–253. [PubMed] [Google Scholar]
- Swenberg J. A., Short B., Borghoff S., Strasser J., Charbonneau M. The comparative pathobiology of alpha 2u-globulin nephropathy. Toxicol Appl Pharmacol. 1989 Jan;97(1):35–46. doi: 10.1016/0041-008x(89)90053-7. [DOI] [PubMed] [Google Scholar]
- Tennant R. W., Elwell M. R., Spalding J. W., Griesemer R. A. Evidence that toxic injury is not always associated with induction of chemical carcinogenesis. Mol Carcinog. 1991;4(6):420–440. doi: 10.1002/mc.2940040604. [DOI] [PubMed] [Google Scholar]
- Tomatis L., Narod S., Yamasaki H. Transgeneration transmission of carcinogenic risk. Carcinogenesis. 1992 Feb;13(2):145–151. doi: 10.1093/carcin/13.2.145. [DOI] [PubMed] [Google Scholar]
- Weinstein I. B. Mitogenesis is only one factor in carcinogenesis. Science. 1991 Jan 25;251(4992):387–388. doi: 10.1126/science.1989073. [DOI] [PubMed] [Google Scholar]